Practical Dermatology
Providing the latest developments in medical and cosmetic dermatology.
From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions - PracticalDermatology
From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions - PracticalDermatology
IMMpactful: Risankizumab Outperforms Deucravacitinib in Moderate Psoriasis at 16 Weeks - - PracticalDermatology
IMMpactful: Risankizumab Outperforms Deucravacitinib in Moderate Psoriasis at 16 Weeks - - PracticalDermatology
Risankizumab achieved higher rates of PASI 90 and PASI 100 compared with deucravacitinib at 16 weeks, alongside greater improvements in patient-reported s…
TRuE-AD4: Ruxolitinib Cream Improves QoL and Sleep in Moderate AD - - PracticalDermatology
TRuE-AD4: Ruxolitinib Cream Improves QoL and Sleep in Moderate AD - - PracticalDermatology
Ruxolitinib cream 1.5% demonstrated consistent improvements in patient-reported outcomes among adults with moderate atopic dermatitis (AD) who previously …
AD-VISE: Better Patient Outcomes Tied to Achieving MDA at 6 Months - - PracticalDermatology
AD-VISE: Better Patient Outcomes Tied to Achieving MDA at 6 Months - - PracticalDermatology
Patients with atopic dermatitis (AD) treated with upadacitinib who achieved minimal disease activity (MDA) demonstrated markedly improved patient-reported…
Long-term Upadacitinib Data Show Low Rates of MACE, Malignancy - - PracticalDermatology
Long-term Upadacitinib Data Show Low Rates of MACE, Malignancy - - PracticalDermatology
Long-term safety data from three phase 3 trials (Measure Up 1, Measure Up 2, and AD Up) provided a 6-year view of upadacitinib in moderate-to-severe atopi…
ICONIC-LEAD: Durable Psoriasis Clearance Through 52 Weeks with Icotrokinra - - PracticalDermatology
ICONIC-LEAD: Durable Psoriasis Clearance Through 52 Weeks with Icotrokinra - - PracticalDermatology
The US Food and Drug Administration (FDA) recently granted approval for the oral interleukin (IL)-23 receptor antagonist icotrokinra (ICOTYDE™, Johnson &a…
What New Secukinumab Data Mean for HS Patients: A Q&A with Dr. April Armstrong - - PracticalDermatology
What New Secukinumab Data Mean for HS Patients: A Q&A with Dr. April Armstrong - - PracticalDermatology
In the following Q&A, Dr. April Armstrong, professor and chief of dermatology at UCLA, chats with Practical Dermatology about new long-term data and k…
Bimekizumab Shows Durable Psoriasis Clearance and 3-Year HS Control - - PracticalDermatology
Bimekizumab Shows Durable Psoriasis Clearance and 3-Year HS Control - - PracticalDermatology
New analyses from the BE RADIANT and BE VIVID trials presented at the 2026 American Academy of Dermatology Annual Meeting in Denver showed the durability …
Cannabis Use Linked to Lower BCC Risk, No Change in Melanoma or cSCC: Study - - PracticalDermatology
Cannabis Use Linked to Lower BCC Risk, No Change in Melanoma or cSCC: Study - - PracticalDermatology
Cannabis use was linked with decreased incidince of basal cell carcinoma (BCC), but not cutaneous squamous cell carcinoma (cSCC) or malignant melanoma (MM…
Topical Treatments for HS - March 2026 Issue
Topical Treatments for HS - March 2026 Issue
Topical therapies can provide benefit by reducing bacterial burden, decreasing inflammation, and providing symptomatic relief from minor localized flares.
Prospective Data Show Comparable Performance Between AI and Dermatologists - - PracticalDermatology
Prospective Data Show Comparable Performance Between AI and Dermatologists - - PracticalDermatology
A new systematic review and meta-analysis of prospective studies suggests artificial intelligence (AI) systems can acheive diagnostic performance comparab…
The Hidradenitis Suppurativa Therapeutic Pipeline - March 2026 Issue
The Hidradenitis Suppurativa Therapeutic Pipeline - March 2026 Issue
Though treatment options are currently limited, the pipeline for HS therapeutics is active with numerous medications in development.
New Grants Expand Teledermatology Access in the Bronx and Los Angeles - - PracticalDermatology
New Grants Expand Teledermatology Access in the Bronx and Los Angeles - - PracticalDermatology
The George Washington University School of Medicine (GW) and Health Sciences, in collaboration with Pfizer Global Medical Grants, has awarded 2 new grants…
March 2026 - PracticalDermatology
March 2026 - PracticalDermatology
None
Study: Potential Link Between Lesional IgG Autoantibodies and HS Disease Severity - - PracticalDermatology
Study: Potential Link Between Lesional IgG Autoantibodies and HS Disease Severity - - PracticalDermatology
A small biopsy-based study in the Journal of Investigative Dermatology Innovations adds to emerging evidence that humoral immunity may contribute to hidra…
Lutikizumab Improves Clinical Response Rates in Moderate to Severe HS: Analysis - - PracticalDermatology
Lutikizumab Improves Clinical Response Rates in Moderate to Severe HS: Analysis - - PracticalDermatology
In a phase 2, double-blind, placebo-controlled randomized clinical trial, lutikizumab demonstrated efficacy signals in adults with moderate to severe hidr…
Analysis: Long Waits for Pediatric Dermatology Appointments Across US - - PracticalDermatology
Analysis: Long Waits for Pediatric Dermatology Appointments Across US - - PracticalDermatology
Children seeking dermatologic care in the US face long waits regardless of where they are referred, according to a research letter published online in JAM…
FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasis - - PracticalDermatology
FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasis - - PracticalDermatology
Johnson & Johnson announced that the FDA has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and in …
Dermatology Residents Show Gains After Targeted Topical Formulation Education - - PracticalDermatology
Dermatology Residents Show Gains After Targeted Topical Formulation Education - - PracticalDermatology
A small survey-based study found that dermatology residents from 3 training programs reported limited formal education in topical vehicle formulation scie…
ADorable-1 Trial Meets Endpoints for EBGLYSS in Children With Atopic Dermatitis - - PracticalDermatology
ADorable-1 Trial Meets Endpoints for EBGLYSS in Children With Atopic Dermatitis - - PracticalDermatology
Eli Lilly and Company announced positive topline results from the phase 3 ADorable-1 trial of lebrikizumab-lbkz (Ebglyss) in pediatric patients aged 6 mon…
FDA Expands Secukinumab to Adolescents With Moderate to Severe HS - - PracticalDermatology
FDA Expands Secukinumab to Adolescents With Moderate to Severe HS - - PracticalDermatology
Register here for Music City Scale!
Register here for Music City Scale!
BE BOLD: Bimekizumab Shows Superiority Over IL-23 Inhibitor in Psoriatic Arthritis - - PracticalDermatology
BE BOLD: Bimekizumab Shows Superiority Over IL-23 Inhibitor in Psoriatic Arthritis - - PracticalDermatology
Review: Gut Microbiota Dysbiosis Linked With AD, Psoriasis, and HS - - PracticalDermatology
Review: Gut Microbiota Dysbiosis Linked With AD, Psoriasis, and HS - - PracticalDermatology
Baricitinib, Ritlecitinib, and Deuruxolitinib Demonstrate Efficacy in Severe AA - - PracticalDermatology
Baricitinib, Ritlecitinib, and Deuruxolitinib Demonstrate Efficacy in Severe AA - - PracticalDermatology
Diclofenac, Silymarin Show Promise for Preventing Chemotherapy-Induced Hand-Foot Syndrome: Meta-analysis - - PracticalDermatology
Diclofenac, Silymarin Show Promise for Preventing Chemotherapy-Induced Hand-Foot Syndrome: Meta-analysis - - PracticalDermatology
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases - ReachMD
Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases - ReachMD
|NEW ISSUE| March 2024 "Facial Pigmentary Disorders: A Review of Current Treatments"
|NEW ISSUE| March 2024 "Facial Pigmentary Disorders: A Review of Current Treatments"
Not All PDE4 Inhibitors Are the Same
Not All PDE4 Inhibitors Are the Same
Rosacea and Beyond: PDT Patient Success Stories
Rosacea and Beyond: PDT Patient Success Stories
Noah Worcester 2024: Dr. Bar on Surgical Procedures
Noah Worcester 2024: Dr. Bar on Surgical Procedures
Noah Worcester 2024: Dr. Bridges on Practice Management
Noah Worcester 2024: Dr. Bridges on Practice Management
Dapsone Gel Shows Promise for Treating Acne in Skin of Color
Dapsone Gel Shows Promise for Treating Acne in Skin of Color
Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions
Study Shows Pediatric Skin Diseases Have Hidden Impact on Mental Health
Study Shows Pediatric Skin Diseases Have Hidden Impact on Mental Health
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne
The Little Ones: Perspectives on Pediatric Psoriasis and AD
The Little Ones: Perspectives on Pediatric Psoriasis and AD
Benzoyl Peroxide (BPO) Interviews
Benzoyl Peroxide (BPO) Interviews
Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming
Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming
New Analysis Provides Evidence-based Recommendations for Vitiligo in Pediatric Patients
New Analysis Provides Evidence-based Recommendations for Vitiligo in Pediatric Patients
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD
How Air Pollution Affects the Skin
How Air Pollution Affects the Skin
Is this the Golden Age of Hair Loss Treatment?
Is this the Golden Age of Hair Loss Treatment?
Report: Unacceptably High Benzene Levels Detected in Numerous Acne Products Containing BPO
Report: Unacceptably High Benzene Levels Detected in Numerous Acne Products Containing BPO
How Ichthyosis Can Affect Mental Health—And How We Can Address It
How Ichthyosis Can Affect Mental Health—And How We Can Address It
Six Dermatology Biotechs Combine to Form Alys Pharmaceuticals
Six Dermatology Biotechs Combine to Form Alys Pharmaceuticals
Social Media as a Force for Good: How to Think Like a B Corp - Practical Dermatology
Social Media as a Force for Good: How to Think Like a B Corp - Practical Dermatology
Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review
Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review
The Importance of Keeping Up with New Developments
The Importance of Keeping Up with New Developments
Achieve Skin Tightening in 1-2-3 - Practical Dermatology
Achieve Skin Tightening in 1-2-3 - Practical Dermatology
Why Assessing Vitiligo Activity is Critical for Limiting Spread - Practical Dermatology
Why Assessing Vitiligo Activity is Critical for Limiting Spread - Practical Dermatology
How Combination Treatments Can Address Unmet Needs
How Combination Treatments Can Address Unmet Needs
How Dermatological Practices Can Integrate Clinical Research - Practical Dermatology
How Dermatological Practices Can Integrate Clinical Research - Practical Dermatology
Study: Transgender Individuals Experience Stigma, Treatment Barriers - Practical Dermatology
Study: Transgender Individuals Experience Stigma, Treatment Barriers - Practical Dermatology
What’s Great About Your Practice? And Why Does That Really Matter? - Practical Dermatology
What’s Great About Your Practice? And Why Does That Really Matter? - Practical Dermatology
Angioleiomyoma in a Rare Location - Practical Dermatology
Angioleiomyoma in a Rare Location - Practical Dermatology
Treatment of Psychodermatological Conditions Using N-acetylcysteine
Treatment of Psychodermatological Conditions Using N-acetylcysteine
Vitiligo: An Update on Treatment Options
Vitiligo: An Update on Treatment Options
DermWireTV
DermWireTV
Physician Spotlight: Sue Ellen Cox, MD
Physician Spotlight: Sue Ellen Cox, MD
Regenerative Medicine in Action: Reprogramming Tissue Mechanically to Heal Wounds, Rejuvenate Skin
Regenerative Medicine in Action: Reprogramming Tissue Mechanically to Heal Wounds, Rejuvenate Skin
Dealing With Unhappy Cosmetic Patients
Dealing With Unhappy Cosmetic Patients
Demystifying Itch: Does S. aureus Kickstart a Molecular Chain Reaction That Culminates in the Urge to Scratch?
Demystifying Itch: Does S. aureus Kickstart a Molecular Chain Reaction That Culminates in the Urge to Scratch?
More Photos of Patients with Psoriasis Needed in Studies
More Photos of Patients with Psoriasis Needed in Studies
How Early Experience With PDT Can Provide Career Pathways
How Early Experience With PDT Can Provide Career Pathways
YoungMD Connect | Dermatology & Aesthetics
YoungMD Connect | Dermatology & Aesthetics
Subscribe to Practical Dermatology today!
Subscribe to Practical Dermatology today!
Facebook
Facebook
LinkedIn
LinkedIn
X
X
Instagram
Instagram
View on mobile
Explore other Linktrees
babynezz
@babynezz
Be Fat Be Happy
@befatbehappy
Keiko Lynn
@keikolynn
BNC Map
@bncmap
goodnoticingspod
@goodnoticingspod
Kaitlyn Johnson
@missynjohnson
TJ Palma
@tjpalma
Caroline Ricke
@carolinericke
Alli Weatherly
@alliweatherly
jumperspodcast
@jumperspodcast
previous
next
Discover more
See all
@miscelaniaportao
@nstx6
@arcaneaccessories
@utkphilamb
@jaimereyna
@ivanadabila28
@littlepersimmons
@plasalaundry
@LAST.Official
@vogeseykeychain
@flutterkualalumpur
@rawtraveltv
@kebabmediterraneo
@studiofresh
@insyirahalya2324
@periodrecoverydietitian
@KeraWyckoff
@NatasyaMohamad
@camoes500
@vangkassy
@mishica66
@Egulos
@dbeltrandigital
@irakozechris14
@nascencemidwife
@oMentolado
@noins.id
@mylacontenthouse
@alltypeltd
@huilerie.saint.michel
@pincerofficial
@sonoestro
@jacada.williams
@SchultzFamilyCards
@emilecoachvocal
@lesenchanteurs
@Gabriela.Isabel.Joyas
@Shalva.B
@rodcouto
@blezourblec
@servicios.esenciapaisajes
@bbspecial2000
@vantiss
@Steamfox
@concarodescubreyanbal